Blood grown in a laboratory has been transfused into two volunteers in the world’s first clinical trials that will likely revolutionise treatments for patients with rare blood types or sickle cell disease.
The lab-manufactured blood cells were grown from stem cells from donors and were transfused in quantities of around 5-10ml – about one to two teaspoons – into volunteers.
